The con­cept in brief — Light into the dark­ness: Model-based Pul­se Wave Ana­ly­sis (mbPWA)

Revo­lu­tio­na­ri­ly different

Game-chan­ging precision

Rethin­king Diagnostics

Pro­tec­ting heart and arte­ries more effec­tively than ever before

The con­cept in brief

Light into the Dark: Model-based Pul­se Wave Ana­ly­sis (mbPWA)

We have inven­ted a mea­su­re­ment method based on arti­fi­ci­al intel­li­gence that looks at car­dio­vas­cu­lar health from an enti­re­ly new angle.

Far supe­ri­or to con­ven­tio­nal mea­su­re­ment methods, our approach excels in ultra­high pre­cis­i­on of the values deter­mi­ned, com­bi­ned with out­stan­ding usa­bi­li­ty and pati­ent benefit.

Mea­su­re heart and arte­ries — detect risks earlier

Ear­ly and, ide­al­ly, regu­lar moni­to­ring based on relia­ble mea­su­re­ment data is essen­ti­al to pro­tect the heart and arte­ries and main­tain car­dio­vas­cu­lar func­tion­a­li­ty for as long as possible.

Valid, sci­ence-based state­ments about the indi­vi­du­al heart and vas­cu­lar con­di­ti­on are essen­ti­al to iden­ti­fy car­dio­vas­cu­lar dise­a­se risks (heart fail­ure, car­diac infarc­tion, etc.) or peri­phe­ral cir­cu­la­to­ry dis­or­ders (e.g., peri­phe­ral arte­ri­al dise­a­se, PAD).

Whe­re con­ven­tio­nal mea­su­re­ment methods fail

The han­di­cap of all cur­rent mea­su­re­ment tech­ni­ques lies in the cir­cui­tous deter­mi­na­ti­on of car­dio­vas­cu­lar data via sur­ro­ga­te para­me­ters such as Aug­men­ta­ti­on Index (AIx), Pul­se Wave Velo­ci­ty (PWV), or Flow Media­ted Dila­ti­on (FMD).

Car­dio­vas­cu­lar data, thus obtai­ned only indi­rect­ly via ana­ly­ti­cal ‘dis­sec­tion’ of fea­tures of the pul­se wave­form, shows unsa­tis­fac­to­ri­ly low pre­cis­i­on. The­r­e­fo­re, the mea­su­re­ment results lack both vali­di­ty and plau­si­bi­li­ty. Even worse, limi­ta­ti­ons in arte­ri­al dila­ta­bi­li­ty are repor­ted signi­fi­cant­ly too late due to low sensitivity.

Mea­su­ring direct­ly ins­tead of indirectly

Pro­blem sol­ved: Our solu­ti­on is Model-based Pul­se Wave Ana­ly­sis (mbPWA). Spe­ci­al­ly desi­gned mea­su­re­ment algo­rith­ms are at the heart of this revo­lu­tio­na­ry novel mea­su­re­ment method. Thus, it is pos­si­ble to deter­mi­ne the wall stiff­ness and flow resis­tance of the arte­ries within a few minu­tes. Bes­i­des, for the first time, mbPWA also pro­vi­des valuable car­diac para­me­ters such as prel­oad, after­load, and con­trac­ti­li­ty all in one go.

We crea­te a pati­ent-spe­ci­fic arte­ri­al image based on a vir­tual­ly simu­la­ted arte­ri­al tree. Thus, we can deter­mi­ne the indi­vi­du­al car­dio­vas­cu­lar health of each pati­ent within minu­tes, with unpre­ce­den­ted accu­ra­cy and con­clu­si­ve­ness — non-inva­si­ve­ly, yet still direct­ly.

Doc­tors and pati­ents bene­fit likewise

For doc­tors: Unbeat­a­b­ly pre­cise in the deter­mi­na­ti­on of values, at the same time uncom­pli­ca­ted and time-saving when in ope­ra­ti­on. The mea­su­re­ment can easi­ly be dele­ga­ted: pre­vious­ly with VASCASSIST 1 and 2, from 2023 on with the new appli­ance gene­ra­ti­on ERKAMETER 133. After a short cal­cu­la­ti­on time of the easy-to-use, cor­re­spon­ding soft­ware pro­gram VASCVIEWER, the dia­gno­sis is only a few clicks away with the help of the vas­cu­lar ava­tar crea­ted by the neu­ral network.

Pati­ents bene­fit from a pain­less, effort­less exami­na­ti­on with cer­tain­ty in minu­tes: No ner­ve-wrack­ing wait for results.